Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behnam Nabet

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Nature Chemical Biology|June 3, 2020
Identification of a potent and selective covalent Pin1 inhibitorBenika J Pinch, Zainab M Doctor, Behnam Nabet, et al.
Nature|March 28, 2024
Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNFSandi Radko-Juettner, Hong Yue, Jacquelyn A Myers, et al.
Nature|April 29, 2024
Author Correction: Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNFSandi Radko-Juettner, Hong Yue, Jacquelyn A Myers, et al.
Cell Reports|October 3, 2019
Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven CancersRita Sulahian, Jason J Kwon, Katherine H Walsh, et al.
Genes & Development|March 18, 2022
A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemiaTaku Harada, Yaser Heshmati, Jérémie Kalfon, et al.
Nature Chemical Biology|April 7, 2020
Discovery of a selective inhibitor of doublecortin like kinase 1Fleur M Ferguson, Behnam Nabet, Srivatsan Raghavan, et al.
Nature|July 13, 2013
A compendium of RNA-binding motifs for decoding gene regulationDebashish Ray, Hilal Kazan, Kate B Cook, et al.
The Journal of Clinical Investigation|December 24, 2024
Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer modelsDezhi Li, Ke Geng, Yuan Hao, et al.
Nature Chemical Biology|May 11, 2021
Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivoChristian Dubiella, Benika J Pinch, Kazuhiro Koikawa, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Nature Chemical Biology|June 3, 2020
Identification of a potent and selective covalent Pin1 inhibitorBenika J Pinch, Zainab M Doctor, Behnam Nabet, et al.
Nature|March 28, 2024
Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNFSandi Radko-Juettner, Hong Yue, Jacquelyn A Myers, et al.
Nature|April 29, 2024
Author Correction: Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNFSandi Radko-Juettner, Hong Yue, Jacquelyn A Myers, et al.
Cell Reports|October 3, 2019
Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven CancersRita Sulahian, Jason J Kwon, Katherine H Walsh, et al.
Genes & Development|March 18, 2022
A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemiaTaku Harada, Yaser Heshmati, Jérémie Kalfon, et al.
Nature Chemical Biology|April 7, 2020
Discovery of a selective inhibitor of doublecortin like kinase 1Fleur M Ferguson, Behnam Nabet, Srivatsan Raghavan, et al.
Nature|July 13, 2013
A compendium of RNA-binding motifs for decoding gene regulationDebashish Ray, Hilal Kazan, Kate B Cook, et al.
The Journal of Clinical Investigation|December 24, 2024
Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer modelsDezhi Li, Ke Geng, Yuan Hao, et al.
Nature Chemical Biology|May 11, 2021
Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivoChristian Dubiella, Benika J Pinch, Kazuhiro Koikawa, et al.
Pageof 6